Twin Boost for TB Treatment in Swaziland
April 11, 2011
Swaziland will soon roll out a fast, cheap test to detect drug-resistant TB strains, and it will begin paying community counselors to directly observe drug-resistant TB patients take their medication. A $40 million grant from the Global Fund to Fight AIDS, TB and Malaria will be used to fund the initiatives.
Swaziland is hoping to decentralize TB services with a new multidrug-resistant TB (MDR TB) test called Gene Xpert, which is approved by the World Health Organization. Yielding results in less than two hours, the Gene Xpert test costs just $16 per patient.
"Before the end of the year, government will have accredited 31 more clinics to diagnose and initiate TB treatment," said Themba Dlamini, national TB coordinator. The new MDR TB test "will also be used at clinics because it doesn't have a lot of bio-safety requirements. It is also very reliable when used correctly."
Community-based counselors who ensure treatment adherence among MDR TB patients will be paid $60 a month. The goal is to have a trained health motivator to support every MDR TB patient, said Dlamini.
"Most patients take their medication in the evening and it's dangerous for us to walk back home," said counselor Albertina Nyatsi, explaining how a stipend will help. "I need money for transport."
Inter Press Service
04.06.2011; Mantoe Phakathi
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)